ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
9
views
0
references
Top references
cited by
7
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,412
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Phase 1 safety and clinical activity of BLU-554 in advanced hepatocellular carcinoma (HCC)
Author(s):
R KIM
,
D. Sarker
,
T Macarulla
,
T Yau
,
S.P. Choo
,
T. MEYER
,
A. Hollebecque
,
J Whisenant
,
M. Sung
,
J.-H. Yoon
,
H.Y. Lim
,
A. ZHU
,
J.-W. PARK
,
S Faivre
,
V Mazzaferro
,
H SHI
,
O. Schmidt-Kittler
,
C. CLIFFORD
,
B Wolf
,
Y.-K. Kang
,
T YAU
,
S. T. Choo
,
T Meyer
,
SP Choo
,
JH Yoon
,
HY Lim
,
JW Park
,
C Clifford
,
YK Kang
,
L. DÍAZ
,
A Marabelle
,
TW Kim
,
R Geva
,
E van Cutsem
,
T Andre
,
PA Ascierto
,
M. MAIO
,
JP Delord
,
M GOTTFRIED
,
L Díaz
,
E Van Cutsem
,
A Ascierto
,
J. Delord
,
M. Gottfried
Publication date:
2017
Journal:
Annals of Oncology
Read this article at
ScienceOpen
Publisher
Further versions
open (via crossref license)
Powered by
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
RNA drug delivery
Author and article information
Journal
DOI::
10.1093/annonc/mdx367
ScienceOpen disciplines:
Pharmacology & Pharmaceutical medicine
Data availability:
ScienceOpen disciplines:
Pharmacology & Pharmaceutical medicine
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,412
Improvements in cough severity and cough-related quality of life in a phase 2 trial (RELIEF) with the P2X3 antagonist BLU-5937 in refractory chronic cough (RCC)
Authors:
SS Birring
,
JA Smith
,
AH Morice
…
BLU-701 is a highly potent, brain-penetrant and WT-sparing next-generation EGFR TKI for the treatment of sensitizing (ex19del, L858R) and C797S resistance mutations in metastatic NSCLC
Authors:
C CONTI
,
J. CAMPBELL
,
R. WOESSNER
Blu-Ice
and the
Distributed Control System
: software for data acquisition and instrument control at macromolecular crystallography beamlines
Authors:
Timothy McPhillips
,
Scott E. McPhillips
,
Hsiu-Ju Chiu
…
See all similar
Cited by
7
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
Authors:
Xiang-Yuan Luo
,
Kong-Ming Wu
,
Xing-Xing He
Targeted and novel therapy in advanced gastric cancer
Authors:
Julie H Selim
,
Shagufta Shaheen
,
Wei-Chun Sheu
…
New clinical trial designs in the era of precision medicine
Authors:
Elena Garralda
,
Rodrigo Dienstmann
,
Alejandro Piris-Gimenez
…
See all cited by